A safety, tolerability, pharmacokinetics (PK) and target engagement (TE) study of GSK3858279 in healthy participants and evaluation of the efficacy of repeat doses in participants with osteoarthritis (OA)

Trial Identifier: 207804
Sponsor: GlaxoSmithKline
Collaborator:
N/A
Start Date: May 2018
Primary Completion Date: September 2022
Study Completion Date: September 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Germany, Berlin Berlin, Germany, 10117
Poland Warsaw, Poland, 02-106
United Kingdom Cambridge, United Kingdom, CB2 2GG
United Kingdom London, United Kingdom, NW10 7EW
United Kingdom Manchester, United Kingdom, M13 9NQ